行情

DRIO

DRIO

DarioHealth
NASDAQ

实时行情|Nasdaq Last Sale

13.88
+0.04
+0.29%
盘后: 13.88 0 0.00% 16:14 09/24 EDT
开盘
13.65
昨收
13.84
最高
14.35
最低
13.50
成交量
13.95万
成交额
--
52周最高
31.85
52周最低
10.01
市值
2.29亿
市盈率(TTM)
-3.2051
分时
5日
1月
3月
1年
5年
DarioHealth 将参加 Cantor Fitzgerald 虚拟全球医疗保健会议
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual Global Healthcare Conference, which is being held September 27-3...
PR Newswire · 2天前
迫切需要解决方案,糖尿病和肥胖医疗保健部门在创新技术中寻找答案和希望
/PRNewswire/ -- Navigating today's healthcare systems can be overwhelming. Outrageous costs combined with complex processes have created a healthcare system renowned for overpriced inefficiency; PolicyAdvice reported that in 2018, the global healthcare mar...
PR Newswire - PRF · 3天前
InvestorNewsBreaks DarioHealth Corp. (NASDAQ: DRIO) Exec 在美国健康保险计划全国会议上的特邀演讲者
(MENAFN - Investor Brand Network) DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, has announced that chief medical officer Dr. Omar Manejwala will participate in the upcoming annual American Health Insurance Plans National...
MENAFN · 09/17 22:31
DarioHealth 首席医疗官 Omar Manejwala 博士在美国健康保险计划全国会议上发表讲话,讨论医疗保险、医疗补助和双重资格
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual American Health Insurance Plans National Conference on Medicare,...
PR Newswire · 09/17 10:40
简报-DarioHealth Corp 达成协议,向东北地区的一家雇主提供其数字治疗套件
reuters.com · 09/09 11:08
东北地区雇主选择 DarioHealth
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a ...
PR Newswire - PRF · 09/09 10:40
DarioHealth 赢得数字治疗套件合同
MT Newswires · 09/09 08:27
InvestorNewsBreaks DarioHealth Corp.(纳斯达克股票代码:DRIO)签署行为健康服务合同,雇主市场持续增长
(MENAFN - Investor Brand Network)
MENAFN · 09/08 18:40
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解DRIO最新的财务预测,通过DRIO每股收益,每股净资产,每股现金流等数据分析DarioHealth近期的经营情况,然后做出明智的投资选择。
分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测DRIO价格均价为27.53,最高价位35.00,最低价为12.75。
EPS
机构持股
总机构数: 70
机构持股: 909.03万
持股比例: 55.06%
总股本: 1,650.94万
类型机构数股数
增持
18
218.96万
建仓
24
111.72万
减持
12
18.59万
平仓
19
102.21万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-0.61%
医疗设备和用品
-0.42%
高管信息
Non-Executive Chairman/Independent Director
Yoav Shaked
President/General Manager
Richard Anderson
Chief Executive Officer/Director
Erez Raphael
Chief Financial Officer/Treasurer/Secretary
Zvi Ben-David
Chief Operating Officer
Dror Bacher
Senior Vice President/Director of Sales
Chris Chan
Vice President
Claudia Kraut
General Manager
Oded Cohen
Director
Adam Stern
Independent Director
Hila Karah
Independent Director
Dennis Matheis
Independent Director
Dennis Mcgrath
Independent Director
Richard Stone
暂无数据
DRIO 简况
DarioHealth Corp(原名:Labstyle Innovations Corp)是一家数字健康(mHealth)公司。该公司开发和商业化技术,为消费者通过智能手机和其他移动设备提供实验室测试能力。该公司的产品Dario(或Dario智能糖尿病管理解决方案)是一个基于软件应用的移动实时糖尿病云管理解决方案,并与袖珍型血糖监测设备Dario Smart Meter配套使用。Dario产品是一种数字糖尿病管理解决方案,该产品通过iPhone或Android的软件应用提供的技术,并通过血糖监测系统设备提供云数据服务。Dario允许用户记录、分析、传输和存储多种数据点,如葡萄糖水平、胰岛素和碳水化合物摄入量。该公司在荷兰和新西兰销售Dario智能糖尿病管理解决方案。

微牛提供DarioHealth Corp(NASDAQ-DRIO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的DRIO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易DRIO股票基本功能。